SeaStar Medical Holding Statistics
Total Valuation
ICU has a market cap or net worth of $4.41 million. The enterprise value is $421,691.
| Market Cap | 4.41M |
| Enterprise Value | 421,691 |
Important Dates
The last earnings date was Wednesday, November 11, 2026, after market close.
| Earnings Date | Nov 11, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
ICU has 5.26 million shares outstanding. The number of shares has increased by 211.61% in one year.
| Current Share Class | 5.26M |
| Shares Outstanding | 5.26M |
| Shares Change (YoY) | +211.61% |
| Shares Change (QoQ) | +7.50% |
| Owned by Insiders (%) | 0.87% |
| Owned by Institutions (%) | 4.45% |
| Float | 5.21M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 2.04 |
| Forward PS | n/a |
| PB Ratio | 6.87 |
| P/TBV Ratio | 9.40 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.19 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.03, with zero debt.
| Current Ratio | 1.03 |
| Quick Ratio | 0.86 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -516.93 |
Financial Efficiency
Return on equity (ROE) is -246.11% and return on invested capital (ROIC) is -157.03%.
| Return on Equity (ROE) | -246.11% |
| Return on Assets (ROA) | -89.92% |
| Return on Invested Capital (ROIC) | -157.03% |
| Return on Capital Employed (ROCE) | -3,196.38% |
| Weighted Average Cost of Capital (WACC) | -1.50% |
| Revenue Per Employee | $120,278 |
| Profits Per Employee | -$815,778 |
| Employee Count | 18 |
| Asset Turnover | 0.21 |
| Inventory Turnover | 2.50 |
Taxes
In the past 12 months, ICU has paid $3,000 in taxes.
| Income Tax | 3,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -83.21% in the last 52 weeks. The beta is -1.04, so ICU's price volatility has been lower than the market average.
| Beta (5Y) | -1.04 |
| 52-Week Price Change | -83.21% |
| 50-Day Moving Average | 2.93 |
| 200-Day Moving Average | 3.29 |
| Relative Strength Index (RSI) | 20.82 |
| Average Volume (20 Days) | 284,661 |
Short Selling Information
The latest short interest is 175,168, so 3.33% of the outstanding shares have been sold short.
| Short Interest | 175,168 |
| Short Previous Month | 185,839 |
| Short % of Shares Out | 3.33% |
| Short % of Float | 3.36% |
| Short Ratio (days to cover) | 0.72 |
Income Statement
In the last 12 months, ICU had revenue of $2.17 million and -$14.68 million in losses. Loss per share was -$3.66.
| Revenue | 2.17M |
| Gross Profit | 2.01M |
| Operating Income | -14.99M |
| Pretax Income | -14.68M |
| Net Income | -14.68M |
| EBITDA | n/a |
| EBIT | -14.99M |
| Loss Per Share | -$3.66 |
Balance Sheet
The company has $3.99 million in cash and no debt, with a net cash position of $3.99 million or $0.76 per share.
| Cash & Cash Equivalents | 3.99M |
| Total Debt | n/a |
| Net Cash | 3.99M |
| Net Cash Per Share | $0.76 |
| Equity (Book Value) | 469,000 |
| Book Value Per Share | 0.12 |
| Working Capital | 126,000 |
Cash Flow
| Operating Cash Flow | -13.22M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | n/a |
| Net Borrowing | -16,000 |
| Free Cash Flow | -13.22M |
| FCF Per Share | -$2.51 |
Margins
| Gross Margin | 92.61% |
| Operating Margin | -692.42% |
| Pretax Margin | -678.11% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ICU does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -211.61% |
| Shareholder Yield | -211.61% |
| Earnings Yield | -436.85% |
| FCF Yield | -299.77% |
Analyst Forecast
| Price Target | $10.00 |
| Price Target Difference | 1,092.75% |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | 134.93% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
| Graham Formula Value | n/a |
| Graham Formula Upside | n/a |
Stock Splits
The last stock split was on January 5, 2026. It was a reverse split with a ratio of 1:10.
| Last Split Date | Jan 5, 2026 |
| Split Type | Reverse |
| Split Ratio | 1:10 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |